STREXIT2 at the EU Cancer Mission’s 5th Anniversary Event: Stronger Through Connection
From 29 September to 1 October 2026, the STREXIT2 consortium was represented at “5 Years EU Cancer Mission:...
We are a multidisciplinary and multistakeholder consortium involving clinical oncologists, surgeons, health economists and patient representatives. The study design was successfully discussed with patients. This action is part of the Cancer Mission cluster of projects on ‘Diagnosis and treatment’.
From 29 September to 1 October 2026, the STREXIT2 consortium was represented at “5 Years EU Cancer Mission:...
Traditional clinical trials are essential for determining whether new treatments are safe and effective. However, the highly controlled conditions...
We are happy to announce a new blog series created in collaboration between the Sarcoma Patient Advocacy Global...
© The STREXIT2 Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101103843). Views and opinions expressed are however those of the authors only and do not necessarily
reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2025 All rights reserved.
